Blood Stream Infection Clinical Trials

7 recruitingLast updated: May 13, 2026

There are 7 actively recruiting blood stream infection clinical trials across 8 countries. Studies span Not Applicable, Phase 3, Phase 4. Top locations include Aparecida de Goiânia, Goiás, Brazil, Apple Valley, California, United States, Atlanta, Georgia, United States. Updated daily from ClinicalTrials.gov.


Blood Stream Infection Trials at a Glance

7 actively recruiting trials for blood stream infection are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Aparecida de Goiânia, Apple Valley, and Atlanta. Lead sponsors running blood stream infection studies include Hospital Israelita Albert Einstein, IRCCS Azienda Ospedaliero-Universitaria di Bologna, and CorMedix.

Browse blood stream infection trials by phase

Treatments under study

About Blood Stream Infection Clinical Trials

Looking for clinical trials for Blood Stream Infection? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Blood Stream Infection trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Blood Stream Infection clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

Hydrogen Peroxide and Ultraviolet Light for Disinfecting Surfaces in Intensive Care Units

Urinary tract infection (UTI)Infection, HospitalAntimicrobial+2 more
Hospital Israelita Albert Einstein5,000 enrolled12 locationsNCT07233837
Recruiting
Phase 3

Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)

Central Line Associated Blood Stream Infections (CLABSI)
CorMedix200 enrolled15 locationsNCT06822426
Recruiting

Antimicrobial Combination Therapy for Treatment of Enterococcus Faecalis Bacteremia

Blood Stream InfectionGut MicrobiomesEnterococcus Faecalis Infection
IRCCS Azienda Ospedaliero-Universitaria di Bologna510 enrolled4 locationsNCT06833593
Recruiting

Examination of the Large Intestine With Camera Capsule in Patients With Blood Stream Infection With Gut-associated Bacteria

Colorectal Cancer (CRC)Colorectal Cancer and Pre-cancer PolypsBlood Stream Infection+2 more
Odense University Hospital100 enrolled1 locationNCT06919068
Recruiting
Not Applicable

Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction

Central Line Associated Blood Stream Infections (CLABSI)
Swedish Medical Center17,800 enrolled19 locationsNCT07108660
Recruiting
Not Applicable

CLABSI Prevention With Tissue Adhesive

Central Line Associated Blood Stream Infections (CLABSI)
Rabin Medical Center600 enrolled1 locationNCT05721677
Recruiting
Phase 4

EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics

Hospital-Acquired PneumoniaHealthcare associated infectionCarbapenem-Resistant Enterobacteriaceae Infection+2 more
National University of Singapore1,900 enrolled4 locationsNCT05979545